Matches in Wikidata for { <http://www.wikidata.org/entity/Q33376325> ?p ?o ?g. }
- Q33376325 description "2007 nî lūn-bûn" @default.
- Q33376325 description "2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած" @default.
- Q33376325 description "2007 թվականի օգոստոսին հրատարակված գիտական հոդված" @default.
- Q33376325 description "2007年の論文" @default.
- Q33376325 description "2007年論文" @default.
- Q33376325 description "2007年論文" @default.
- Q33376325 description "2007年論文" @default.
- Q33376325 description "2007年論文" @default.
- Q33376325 description "2007年論文" @default.
- Q33376325 description "2007年论文" @default.
- Q33376325 description "2007年论文" @default.
- Q33376325 description "2007年论文" @default.
- Q33376325 description "2007年论文" @default.
- Q33376325 description "2007年论文" @default.
- Q33376325 description "2007年论文" @default.
- Q33376325 description "2007년 논문" @default.
- Q33376325 description "article científic" @default.
- Q33376325 description "article scientific" @default.
- Q33376325 description "article scientifique (publié 2007)" @default.
- Q33376325 description "articol științific" @default.
- Q33376325 description "articolo scientifico" @default.
- Q33376325 description "artigo científico (publicado na 2007)" @default.
- Q33376325 description "artigo científico (publicado na 2007)" @default.
- Q33376325 description "artigo científico" @default.
- Q33376325 description "artikull shkencor" @default.
- Q33376325 description "artikulong pang-agham" @default.
- Q33376325 description "artykuł naukowy" @default.
- Q33376325 description "artículo científico publicado en 2007" @default.
- Q33376325 description "artículu científicu espublizáu en 2007" @default.
- Q33376325 description "bilimsel makale" @default.
- Q33376325 description "bài báo khoa học" @default.
- Q33376325 description "mokslinis straipsnis" @default.
- Q33376325 description "naučni članak" @default.
- Q33376325 description "scienca artikolo" @default.
- Q33376325 description "scientific article" @default.
- Q33376325 description "teaduslik artikkel" @default.
- Q33376325 description "tieteellinen artikkeli" @default.
- Q33376325 description "tudományos cikk" @default.
- Q33376325 description "vedecký článok" @default.
- Q33376325 description "vetenskaplig artikel" @default.
- Q33376325 description "videnskabelig artikel (udgivet 2007)" @default.
- Q33376325 description "vitenskapelig artikkel" @default.
- Q33376325 description "vitskapeleg artikkel" @default.
- Q33376325 description "vědecký článek" @default.
- Q33376325 description "wetenschappelijk artikel" @default.
- Q33376325 description "wissenschaftlicher Artikel" @default.
- Q33376325 description "επιστημονικό άρθρο" @default.
- Q33376325 description "мақолаи илмӣ" @default.
- Q33376325 description "мақолаи илмӣ" @default.
- Q33376325 description "наукова стаття, опублікована в серпні 2007" @default.
- Q33376325 description "научна статия" @default.
- Q33376325 description "научная статья" @default.
- Q33376325 description "научни чланак" @default.
- Q33376325 description "научни чланак" @default.
- Q33376325 description "מאמר מדעי" @default.
- Q33376325 description "سائنسی مضمون" @default.
- Q33376325 description "مقالة علمية" @default.
- Q33376325 description "مقالهٔ علمی" @default.
- Q33376325 description "২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33376325 description "บทความทางวิทยาศาสตร์" @default.
- Q33376325 description "სამეცნიერო სტატია" @default.
- Q33376325 name "Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance" @default.
- Q33376325 name "Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance" @default.
- Q33376325 name "Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance" @default.
- Q33376325 type Item @default.
- Q33376325 label "Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance" @default.
- Q33376325 label "Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance" @default.
- Q33376325 label "Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance" @default.
- Q33376325 prefLabel "Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance" @default.
- Q33376325 prefLabel "Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance" @default.
- Q33376325 prefLabel "Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance" @default.
- Q33376325 P1433 Q33376325-B48942CC-C9B0-4B8A-A3FB-576BBF068EDA @default.
- Q33376325 P1476 Q33376325-448AB6D2-7FBC-443F-A526-CB24F57BDA01 @default.
- Q33376325 P2093 Q33376325-1EE0678E-A09B-4079-BC50-1852B002F38C @default.
- Q33376325 P2093 Q33376325-43DFA2AB-0898-4B9E-B651-AAE92B641AD0 @default.
- Q33376325 P2093 Q33376325-5788FD8C-72AE-4F29-82C2-F3473FD65AD2 @default.
- Q33376325 P2093 Q33376325-6DCBB3D5-4997-490F-BFDA-D88C3127CC8E @default.
- Q33376325 P2093 Q33376325-7E277FE4-199A-4CD5-8657-D9079E0F6557 @default.
- Q33376325 P2093 Q33376325-83CE49BA-9248-4486-B463-F0D02964A0CB @default.
- Q33376325 P2093 Q33376325-878EACE0-9253-4B44-AE85-533BE1F6DC85 @default.
- Q33376325 P2093 Q33376325-97CEC8D7-AB31-4BDD-AE36-D69E309D7175 @default.
- Q33376325 P2093 Q33376325-A055AEC9-5A1E-45AA-86F0-E888A318B7F5 @default.
- Q33376325 P2093 Q33376325-D018C614-E8A0-4FFF-80E1-42C2A9B6C982 @default.
- Q33376325 P2093 Q33376325-EF18A6C4-0E80-4613-9368-AF654D1E38F3 @default.
- Q33376325 P304 Q33376325-8C24955E-7952-4C73-9896-A02FC6A5E164 @default.
- Q33376325 P31 Q33376325-750CC5A5-69B9-450E-A5A6-A49802B524A8 @default.
- Q33376325 P356 Q33376325-44C58597-F0A7-4532-A46A-6FB8219EA3E9 @default.
- Q33376325 P407 Q33376325-F5D6CA42-F218-4E1A-AA0B-719EB96DA47A @default.
- Q33376325 P433 Q33376325-F6FC11D5-ABDE-433F-85DE-C83BBF7DE6AB @default.
- Q33376325 P478 Q33376325-CA9B77BF-9BD4-4484-8BC7-573CB7AB9DF8 @default.
- Q33376325 P50 Q33376325-12E7F4DC-B6F1-4D91-9613-A8D513DC833D @default.
- Q33376325 P50 Q33376325-153FDEC8-DAAD-4319-B4AD-2B7BF28702AD @default.
- Q33376325 P50 Q33376325-28F4063E-7572-4BE9-99BD-25B1C76DB060 @default.
- Q33376325 P50 Q33376325-3407CA95-3F94-4B7C-85BD-27724757C39D @default.
- Q33376325 P50 Q33376325-4B40F093-BA4F-439D-BF02-BB9C9C27FFEC @default.
- Q33376325 P50 Q33376325-A7FE1145-9850-4F7A-98B7-AA6A3E6DDA66 @default.
- Q33376325 P50 Q33376325-D768D905-F5E2-4872-9963-15C67330DE73 @default.
- Q33376325 P577 Q33376325-6AC178A4-EB6E-40A6-997A-B4E925F73358 @default.
- Q33376325 P5875 Q33376325-2AB843FB-D3A6-41EE-BD21-BC485045A193 @default.
- Q33376325 P698 Q33376325-2085057D-ECAA-4A4A-91BF-3757D9226207 @default.